AGC Biologics, a CDMO, signed a purchase agreement for Novartis’ state-of-the-art Cell and Gene Therapy commercial manufacturing facility in Longmont, CO. The facility provides AGC with significant additional capacity and space to expand its end-to-end Cell and Gene Therapy (C&GT) offering, ensuring security of supply for current and future C&GT customers. This facility is only 16 miles from AGC’s state-of-the-art large-scale stainless steel mammalian facility in Boulder, CO.   This ne...